Logo for MiMedx Group Inc

MiMedx Group Investor Relations Material

Latest events

Logo for MiMedx Group Inc

Q1 2024

MiMedx Group
Logo for MiMedx Group

Investor Presentation

1 May, 2024
Logo for MiMedx Group

Q1 2024

30 Apr, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from MiMedx Group Inc

Access all reports
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. MiMedx's products comprise placenta tissue allografts, umbilical cord blood allografts, amniotic membranes and amniotic allografts. The Company’s placental tissue pacification system which is the world’s first non-hormonal device (Harmony), comprises a combination of devices that are temporarily implanted into a patient to help restore normal hormonal and endocrine levels in women who have undergone a hysterectomy or oophorectomy due to cancer. Other products sold by MiMedx include a range of tissue conditioners, skin substitutes and hyaluronic acid gel products.